GB201609977D0 - Chemosensitivity predictive biomarkers - Google Patents
Chemosensitivity predictive biomarkersInfo
- Publication number
- GB201609977D0 GB201609977D0 GBGB1609977.2A GB201609977A GB201609977D0 GB 201609977 D0 GB201609977 D0 GB 201609977D0 GB 201609977 A GB201609977 A GB 201609977A GB 201609977 D0 GB201609977 D0 GB 201609977D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- chemosensitivity
- predictive biomarkers
- biomarkers
- predictive
- chemosensitivity predictive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000035572 chemosensitivity Effects 0.000 title 1
- 239000000092 prognostic biomarker Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1609977.2A GB201609977D0 (en) | 2016-06-08 | 2016-06-08 | Chemosensitivity predictive biomarkers |
| PCT/EP2017/063952 WO2017211947A1 (en) | 2016-06-08 | 2017-06-08 | Chemosensitivity predictive biomarkers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1609977.2A GB201609977D0 (en) | 2016-06-08 | 2016-06-08 | Chemosensitivity predictive biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201609977D0 true GB201609977D0 (en) | 2016-07-20 |
Family
ID=56508232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1609977.2A Ceased GB201609977D0 (en) | 2016-06-08 | 2016-06-08 | Chemosensitivity predictive biomarkers |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201609977D0 (en) |
| WO (1) | WO2017211947A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111286540A (en) * | 2020-03-24 | 2020-06-16 | 中国辐射防护研究院 | Use of POLN gene as molecular marker for predicting radiation sensitivity |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2760851C2 (en) | 2017-01-23 | 2021-11-30 | Регенерон Фармасьютикалз, Инк. | Hsd17b13 options and their applications |
| MX2019012169A (en) | 2017-04-11 | 2019-12-11 | Regeneron Pharma | Assays for screening activity of modulators of members of the hydroxysteroid (17-beta) dehydrogenase (hsd17b) family. |
| KR102694809B1 (en) | 2017-10-11 | 2024-08-16 | 리제너론 파마슈티칼스 인코포레이티드 | Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M mutation |
| CN108441556A (en) * | 2018-01-04 | 2018-08-24 | 大连医科大学附属第二医院 | CircZNF521 is applied in pituitary adenoma biomarker |
| AU2019239971B2 (en) | 2018-03-21 | 2025-09-11 | Regeneron Pharmaceuticals, Inc. | 17beta-hydroxysteroid dehydrogenase type 13 (HSD17b13) iRNA compositions and methods of use thereof |
| KR102200428B1 (en) * | 2018-05-16 | 2021-01-08 | 주식회사 지놈앤컴퍼니 | Pharmaceutical composition for preventing or treating cancer comprising lrit2 inhibitor as active ingredient |
| CN108384850A (en) * | 2018-05-23 | 2018-08-10 | 北京泱深生物信息技术有限公司 | Childhood asthma early diagnosis marker and its application |
| CN108998529A (en) * | 2018-08-30 | 2018-12-14 | 上海交通大学医学院附属上海儿童医学中心 | Adenocarcinoma of lung detection kit and the method for detecting TULP2 gene methylation level |
| CN109486934A (en) * | 2018-10-18 | 2019-03-19 | 中国医学科学院北京协和医院 | CWF19L2 gene is preparing the application in Diagnosis of osteoporosis product |
| AU2019370860A1 (en) * | 2018-11-04 | 2021-06-24 | Pfs Genomics, Inc. | Methods and genomic classifiers for prognosis of breast cancer and predicting benefit from adjuvant radiotherapy |
| CN109701018B (en) * | 2018-12-29 | 2021-08-13 | 中国科学院合肥物质科学研究院 | Application of targeted interference of GOLPH3 gene expression in improving radiosensitivity of non-small cell lung cancer |
| CN109762836A (en) * | 2019-01-30 | 2019-05-17 | 山西医科大学第一医院 | Preparation method of eukaryotic expression protein monomer of human laryngeal squamous cell carcinoma-related gene SKA3 |
| WO2021177898A1 (en) * | 2020-03-03 | 2021-09-10 | National University Of Singapore | Method for determining the likelihood of resistance to therapy |
| CN111521791A (en) * | 2020-04-21 | 2020-08-11 | 山东第一医科大学(山东省医学科学院) | A kit and detection method for detecting NSE gene mutation in peripheral blood circulating tumor cells of patients with small cell lung cancer |
| CN111521794A (en) * | 2020-04-21 | 2020-08-11 | 山东第一医科大学(山东省医学科学院) | Immunofluorescence kit and detection method for detecting NSE gene mutation of peripheral blood circulating tumor cells of small cell lung cancer patients |
| GB2595718A (en) * | 2020-06-04 | 2021-12-08 | Cancer Research Tech Ltd | Methods for predicting treatment response in cancers |
| JP2023532199A (en) * | 2020-06-17 | 2023-07-27 | ユニヴァーシティー オブ ユタ リサーチ ファウンデーション | Biomarker-based patient selection for proteasome inhibitor therapy |
| CN112195248A (en) * | 2020-11-12 | 2021-01-08 | 江西省肿瘤医院(江西省癌症中心) | Application of lncRNA DLEU1 as glioma temozolomide drug resistance detection, treatment and prognosis molecular target |
| CN112415199B (en) * | 2020-11-20 | 2023-09-08 | 四川大学华西医院 | Use of CETP detection reagents in preparing lung cancer screening kits |
| JP2022092591A (en) * | 2020-12-10 | 2022-06-22 | 国立大学法人信州大学 | Method for determining therapeutic effect on melanoma patient |
| CN112509636B (en) * | 2020-12-21 | 2024-03-15 | 上海科技大学 | A method for identifying tumor genome copy number variation characteristic patterns and its application |
| CN112852969B (en) * | 2021-04-19 | 2022-06-10 | 温州医科大学 | Epigenetically modified lncRNA as tumor diagnosis or tumor progression prediction marker |
| CN114438232B (en) * | 2022-03-11 | 2023-06-23 | 浙江省农业科学院 | SNPs molecular marker g.43917 A>G and its application in marker-assisted breeding of Hu sheep |
| CN114875153B (en) * | 2022-06-18 | 2023-09-15 | 瓯江实验室 | Predictive target CRTAC1 for precision chemotherapy in non-small cell lung cancer and its application |
| CN115927645B (en) * | 2023-02-07 | 2024-07-26 | 复旦大学附属中山医院 | Application of HNF4G in detecting cisplatin sensitivity in lung adenocarcinoma |
| CN117491636A (en) * | 2023-11-21 | 2024-02-02 | 郑州大学 | A biomarker for lung cancer diagnosis and its application |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101283106A (en) * | 2005-07-27 | 2008-10-08 | 肿瘤疗法科学股份有限公司 | Diagnosis of small cell lung cancer |
| US9512485B2 (en) * | 2010-08-24 | 2016-12-06 | Dana-Farber Cancer Institute. Inc. | Methods for predicting anti-cancer response |
-
2016
- 2016-06-08 GB GBGB1609977.2A patent/GB201609977D0/en not_active Ceased
-
2017
- 2017-06-08 WO PCT/EP2017/063952 patent/WO2017211947A1/en not_active Ceased
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111286540A (en) * | 2020-03-24 | 2020-06-16 | 中国辐射防护研究院 | Use of POLN gene as molecular marker for predicting radiation sensitivity |
| CN111286540B (en) * | 2020-03-24 | 2023-05-12 | 中国辐射防护研究院 | Use of POLN gene as molecular marker for predicting radiation sensitivity |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017211947A1 (en) | 2017-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201609977D0 (en) | Chemosensitivity predictive biomarkers | |
| GB201621631D0 (en) | Predictive modelling | |
| GB2566681B (en) | Biomarker | |
| GB201420908D0 (en) | Biomarkers | |
| GB201614455D0 (en) | Biomarkers | |
| GB201401603D0 (en) | Biomarkers | |
| SG10202007262PA (en) | Copanlisib biomarkers | |
| SG10202007322PA (en) | Copanlisib biomarkers | |
| GB201703058D0 (en) | Biomarkers | |
| ZA202001821B (en) | Biomarker | |
| GB201710858D0 (en) | Biomarker | |
| GB201704267D0 (en) | Novel biomarker | |
| IL241063A0 (en) | Assay for predictive biomarkers | |
| GB201500729D0 (en) | Novel Biomarkers | |
| GB201703123D0 (en) | Biomarkers | |
| GB201814807D0 (en) | Dementia Biomarkers | |
| GB201512133D0 (en) | Biomarkers | |
| GB201811093D0 (en) | Biomarker | |
| EP3164717A4 (en) | Predictive biomarkers | |
| GB201613912D0 (en) | Predictive biomarker | |
| GB201809885D0 (en) | Biomarkers | |
| GB201809872D0 (en) | Biomarkers | |
| GB201809854D0 (en) | Biomarkers | |
| GB201809858D0 (en) | Biomarkers | |
| GB201809862D0 (en) | Biomarkers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |